News

Kimberly-Clark to acquire Kenvue

Published

8 months ago

on

Trading information on Kenvue Inc., a consumer-health business spun off from Johnson & Johnson, is displayed on a screen during the company’s IPO at the New York Stock Exchange in New York City, May 4, 2023.

Brendan Mcdermid | Reuters

Kimberly-Clark said on Monday it will acquire Tylenol-maker Kenvue in a deal valued at about $48.7 billion.

This story is developing. Please check back for updates.

Source link

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version